tiprankstipranks
Orpea SA (MX:ORPN)
LSE:ORPN
Mexico Market

Orpea SA (ORPN) Stock Forecast & Price Target

Followers
See the Price Targets and Ratings of:

ORPN Analyst Ratings

Hold
1Ratings
Hold
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Orpea
SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ORPN Stock 12 Month Forecast

Average Price Target

$317.74
Based on 1 Wall Street analysts offering 12 month price targets for Orpea SA in the last 3 months. The average price target is $317.74 with a high forecast of $317.74 and a low forecast of $317.74. The average price target represents a change from the last price of .
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
Highest Price Target$317.74Average Price Target$317.74Lowest Price Target$317.74
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on MX:ORPN
Kepler Capital
Kepler Capital
$198.59$317.74
Hold
Upgraded
05/19/26
Orpea SA (0NEX) was upgraded to a Hold Rating at Kepler Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on MX:ORPN
Kepler Capital
Kepler Capital
$198.59$317.74
Hold
Upgraded
05/19/26
Orpea SA (0NEX) was upgraded to a Hold Rating at Kepler Capital
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

ORPN Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
1
1
1
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
1
1
2
2
2
In the current month, ORPN has received 0 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. ORPN average Analyst price target in the past 3 months is 317.74.
Each month's total comprises the sum of three months' worth of ratings.

ORPN Financial Forecast

ORPN Earnings Forecast

The previous quarter’s earnings for ORPN were -$19.90.
The previous quarter’s earnings for ORPN were -$19.90.

ORPN Sales Forecast

Next quarter’s sales forecast for ORPN is $30.31B with a range of $30.31B to $30.31B. The previous quarter’s sales results were $59.56B. ORPN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year ORPN has Performed in-line its overall industry.
Next quarter’s sales forecast for ORPN is $30.31B with a range of $30.31B to $30.31B. The previous quarter’s sales results were $59.56B. ORPN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year ORPN has Performed in-line its overall industry.

ORPN Stock Forecast FAQ

What is MX:ORPN’s average 12-month price target, according to analysts?
Based on analyst ratings, Orpea SA’s 12-month average price target is 317.74.
    What is MX:ORPN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:ORPN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Orpea SA a Buy, Sell or Hold?
        Orpea SA has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Orpea SA’s share price target?
          The average share price target for Orpea SA is 317.74. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $317.74 ,and the lowest forecast is $317.74. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Orpea SA?
            Orpea SA’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
              How can I buy shares of Orpea SA?
              To buy shares of MX:ORPN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.